Skip to main navigation Skip to search Skip to main content

Guanidino N-Substituted and N,N-Disubstituted Derivatives of the κ-Opioid Antagonist GNTI

  • Shannon L. Black
  • , Cedric Chauvignac
  • , Peter Grundt
  • , Carl N. Miller
  • , Susan Wood
  • , John R. Traynor
  • , John W. Lewis
  • , Stephen M. Husbands

Research output: Contribution to journalArticlepeer-review

Abstract

Derivatives of the highly selective κ-opioid receptor antagonist GNTI (2a) have been prepared. Binding and functional studies conducted on cloned human opioid receptors expressed in Chinese hamster ovarian (CHO) cells suggested that adding a benzyl or a substituted benzyl group to the guanidino moiety led, in general, to a retention of high κ-affinity and antagonist potency. Disubstitution of the guanidino moiety led to reduced κ-selectivity.

Original languageEnglish (US)
Pages (from-to)5505-5511
Number of pages7
JournalJournal of medicinal chemistry
Volume46
Issue number25
DOIs
StatePublished - Dec 4 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Guanidino N-Substituted and N,N-Disubstituted Derivatives of the κ-Opioid Antagonist GNTI'. Together they form a unique fingerprint.

Cite this